Organic compounds -- part of the class 532-570 series – Organic compounds – Phosphorus acids or salts thereof
Patent
1999-07-21
2000-12-12
Vollano, Jean F
Organic compounds -- part of the class 532-570 series
Organic compounds
Phosphorus acids or salts thereof
562 20, 562 23, 562 24, 562 11, 562 16, C07F 938
Patent
active
061601667
ABSTRACT:
Phosphonic acid agents are synthesized and characterized which are potent inhibitors of angiogenesis, tumorigenesis and metalloproteinase activity. Their method of use for the inhibition of angiogenesis and metalloproteinase and the treatment of tumors is also shown.
REFERENCES:
patent: 3920733 (1975-11-01), Birum
patent: 4372894 (1983-02-01), Helgstrand
patent: 4719297 (1988-01-01), Henne
patent: 4840659 (1989-06-01), Franz
patent: 5652227 (1997-07-01), Teronen
patent: 5670493 (1997-09-01), Cordi
CA;110:107683 abs of Chemotheraphy (Basel) by Strid 35(1) pp. 69-76, 1989.
Beilstein (BRN) 3946113 abs of Tetrahedron Lett by Sekine pp. 3013-3016, 1979.
CA:114:143709 abs of PL 150087, Apr. 1990.
CA:80:4935 abs of JP48006174, Feb. 1973.
CA:78:43620 abs of J Org Chem by Isbell 37(25) pp. 4399-4401, 1972.
CA:112:36035 abs of J Am Chem Soc by Swamy et al 112(1) pp. 223-228, 1990.
"Synthesis and Analytics of Phosphonic Acid Analogues of Suramin and Other Phosphoric Acid Derivatives, Potential Chemotherapeutics Against Filariasis" Dissertation by Mathias Huber, Freie University Berlin, 1982.
Klaus Dieter Jensch, et al. "Inhibition of Human Immunodeficiency Virus Type I Reverse Transcriptase by Suramin-related Compounds," J. gen. Virol. (1987), vol. 68, pp. 2183-2192.
Reinhard Oesterle, et al. "Chemical modifications of aminoaphthalenesosulphanate acid derivatives increase effectivity and specificity of reverse transcriptase inhibition and change mode of action of reverse transcriptase and DNA polymerase alpha inhibition," Antiviral Research (1993) vol. 22, pp. 107-119.
Angela Firsching, et al. "Antiproliferative and Angiostatic Activity of Seramune Analogues," Cancer Research, vol. 55, Nov. 1, 1995, pp. 4957-4961.
CA:82:4363 abs of Z Anorg Allg Chem by Issleib, K., 408(3), 1974, pp. 266-274.
CA:107:190405 abs of J Gen Virol by Jentsch, K., 68(8), 1987, pp. 2183-2192.
CA:120:182336 abs of Antiviral Res by Oesterle R., 22(2-3), 1993, pp. 107-119.
CA:124:44745 abs of Cancer Res by Firsching A., 55(21), 1995, pp. 4957-4961.
CA:77:34992 abs of Sin. Fiz-Khim Polim., by Bakhitov M., No. 8, 1971, pp. 36-41.
STN on line filed Marpat accession No. 128:271686 abstract of CN 1125239, Jun. 26, 1996.
CA:107:190405 abstract of Jentschh, J. Gen. Virol.., 1987, 68(8), pp. 2183-2192
Firsching et al., "Antiproliferative and Angiostatic Activity of Suramin Analogues.sup.1 ", Nov. 1, 19951, Cancer Research 55, 4957-4961.
Sola et al., "Antitumor activity of FCE 26644 a new growth-factor complexing molecule", Cancer Chemother Pharmcol (1995) 36:217-222.
Ciomei et al., "New Sulfonated Distamycin a Derivatives with bFGF Complexing Activity", Biochemical Pharmacology, vol. 47, No. 2, pp. 295-302, 1994.
Database Carplus on STN, Chemical abstracts (Columbia, Ohio), CA No. 126:157635, Cordi et al., "Preparation of aminophenylphosponic acid derivatives, pharmaceutical compositions containing them and their angiogenesis inhibitor activity", abstract EP 754693 A2, Jan. 22, 1997.
Collins Delwood C.
Gagliardi Antonio R.
Nickel Peter
The University of Kentucky Research Foundation
Vollano Jean F
LandOfFree
Phosphonated agents and their antiangiogenic and antitumorigenic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphonated agents and their antiangiogenic and antitumorigenic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphonated agents and their antiangiogenic and antitumorigenic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-219639